ZMEP In The News
RIO(R) Robotic Arm System by MAKO Surgical Corp. Wins 2010 Gold Medical Design Excellence Award
Source: MAKO Surgical Corp
RIO(R) Robotic Arm System by MAKO Surgical Corp. Wins 2010 Gold Medical Design Excellence Award
FT. LAUDERDALE, Fla., June 10, 2010 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO) announced that its RIO® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO® is used to perform MAKOplasty® partial [...]
Aposense Announces Successful Completion of IPO
Company Raises over US $24 Million in IPO and Concurrent Private Placement
Deal Values Aposense at Over US $230 Million
PETACH-TIKVA, Israel, June 7, 2010 – Aposense, a world leader in developing diagnostic and therapeutic drugs based on targeting in vivo apoptosis (programmed cell death), today announced the successful completion of the company’s Initial Public Offering in [...]
GE Healthcare to Purchase Assets of ONI Medical Systems, Inc., Provider of World’s Only High-Field Dedicated Extremity MRI Scanners
• ONI provides high-performance low-cost, dedicated extremity Magnetic Resonance Imaging (MRI) systems; can potentially help reduce patient backlog
• ONI’s high-field scanners designed specifically for imaging of the extremities – exclusively configured to enclose only the joint being imaged
• Claustrophobic patients can sit comfortably for their MRI scan, with image quality comparable to whole-body scanners
• Aligned [...]
IBA and Aposense Sign Strategic Colaboration to Commercialize Aposense(R) ML-10 for Molecular Imaging of Apoptosis
Strengthened collaboration confirms IBA’s leadership in radiopharmaceuticals, Aposense’s drug development capabilities and, their shared mission to provide the new generation of tracers that will take disease diagnostic and treatment to the next level.
Louvain-la-Neuve, Belgium and Petach-Tikva, Israel, September 21, 2009 – IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB), the leading global [...]
Ovalum Ltd. releases for marketing the TraVerse™ micro-catheter in the US
Ovalum Ltd. releases for marketing the TraVerseTM micro-catheter in the US. The TraVerseTM micro-catheter is a unique stainless steel helically laser cut support and exchange catheter used to aid guide wire manipulation in complex angiographic procedures.
Rehovot, Israel (PRWEB) March 1, 2008 — Following approval in Europe, the TraVerseTM micro-catheter will be marketed separately from the [...]
MAKO Surgical Corp. Announces Pricing of Initial Public Offering
FT. LAUDERDALE, Fla., Feb. 14, 2008 (PRIME NEWSWIRE) — MAKO Surgical Corp. announced today the initial public offering of 5,100,000 shares of its common stock at a price of $10.00 per share, all of which shares are being offered by MAKO Surgical Corp. MAKO Surgical Corp. and a selling stockholder have granted the underwriters a [...]
Colonoscopy device gets boost from Ziegler Meditech
From the Milwaukee Journal Sentinel
Benad Goldwasser is a man on a mission: to make colonoscopies easier for doctors and less painful for patients
Working with a team near Tel Aviv, Israel, Goldwasser – a doctor, native Israeli and former college professor – thinks he has found the answer. It’s a high-tech camera embedded in a [...]
ONI Medical Systems, Inc. Secures $12.5 million Funding through Ziegler Meditech Equity Partners
Wilmington, MA – June 28, 2007 – ONI Medical Systems, Inc., developer of the first, truly open, high-field extremity MRI system, announces a $12.5 million capital infusion led by Ziegler Meditech Equity Partners, L.P. The company intends to expand its product development and marketing efforts within the Specialty MRI imaging market.
Ziegler Meditech Equity Partners (ZMEP) [...]
MAKO Surgical Corp. Closes $30 Million In Series C Funding
FORT LAUDERDALE, Fla., Feb. 7 /PRNewswire/ — MAKO Surgical Corp., an emerging orthopedic medical device company developing advanced solutions for least invasive knee surgery, announced today that it has closed on a $30 million Series C private equity financing led by funds affiliated with and advised by Tudor Investment Corporation. The financing also included Ziegler [...]
NST Completes Financing by US Investors, Following Successful Commencement of Clinical Efficacy Studies in Molecular Imaging of Cell Death
NST NeuroSurvival Technologies Ltd. has announced the closing of an additional financing round, in continuation of the company’s financing round of February this year, in which Teva Pharmaceuticals and existing company shareholders have participated. The current round was performed with the participation of the US funds Ziegler-Meditech Equity Partners (ZMEP) and HighBridge Capital. Within their [...]